Podcast
Podcast Episode 24: Five Years after Approval of Voretigene Neparvovec – What is The Future of Retinal Gene Therapy?
In this podcast, Mark Penessi (USA) is joined by Isabelle Audo (FRANCE) and Bart Leroy (BELGIUM) to discuss the impact of Luxturna and how gene therapy products will affect the treatment of inherited retinal diseases (IRD) in the future.
